Last reviewed · How we verify
Frontier Biotechnologies Inc. — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
0 Phase 3
2 Phase 2
2 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
Therapeutic area mix
- Infectious Diseases · 1
- Oncology · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- ASLAN Pharmaceuticals · 1 shared drug class
- ATGC Co., Ltd. · 1 shared drug class
- Addpharma Inc. · 1 shared drug class
- Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class
- Akeso · 1 shared drug class
- Amgen · 1 shared drug class
- Asahi Kasei Pharma Corporation · 1 shared drug class
- 3D Medicines (Sichuan) Co., Ltd. · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Frontier Biotechnologies Inc.:
- Frontier Biotechnologies Inc. pipeline updates — RSS
- Frontier Biotechnologies Inc. pipeline updates — Atom
- Frontier Biotechnologies Inc. pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Frontier Biotechnologies Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/frontier-biotechnologies-inc. Accessed 2026-05-17.